India will be our priority in distributing the coronavirus vaccine, Adar Poonawalla, executive director of the Serum Institute of India, said on Saturday. The world’s largest vaccine manufacturer by volume has teamed up with British-Swedish company AstraZeneca to produce the COVID-19 vaccine for the University of Oxford for low- and …
Read More »
The Serum Institute of India will apply for emergency clearance for the COVID-19 vaccine in the next two weeks, Executive Director Adar Poonawalla said on Saturday. The Pune-based pharmaceutical company has partnered with global pharmaceutical giant AstraZeneca to produce the COVID-19 vaccine for the University of Oxford for low- and …
Read More »
Hopes for an early arrival of a possible vaccine for the coronavirus disease (Covid-19) have been rekindled as several candidate vaccines are in the middle or early stages of late-stage trials. Meanwhile, the total number of people who have contracted the disease worldwide is 58.9 million, while nearly 1.4 million …
Read More »
Trials of different Covid-19 vaccine candidates continue as people around the world contract the coronavirus disease, which has also claimed millions of lives. With many countries, especially in Europe, experiencing a second wave of the pandemic, the need for a Covid-19 vaccine is being felt more and more. Click here …
Read More »
Written by Kaunain Sheriff M | New Delhi | Updated: November 20, 2020 9:52:14 am “Further evaluation of the efficacy of this vaccine is warranted in all age groups and individuals with comorbidities,” the researchers said. The Oxford-AstraZeneca Covid-19 candidate vaccine has triggered a robust immune response in older adults …
Read More »
A ‘safe and effective’ coronavirus vaccine will be available to the general public in the country next May or June, said Adar Poonawalla, executive director of the Serum Institute of India at the Hindustan Times Leadership Summit 2020. The Pune-based drug maker has signed an agreement with British-Swedish company AstraZeneca …
Read More »
Coronavirus Vaccine in India: Bharat Biotech, together with the Indian Council for Medical Research (ICMR) and the National Institute of Virology (NIV), is developing the indigenous coronavirus vaccine Covaxin. Coronavirus vaccine in India: Phase 3 human trials of the indigenous experimental vaccine Covaxin, a candidate for the coronavirus vaccine, are …
Read More »
By: Desk Explained | New Delhi | Updated: November 15, 2020 11:44:36 pm Collecting swabs for rapid Covid-19 testing at a municipal dispensary in Deonar in Mumbai (Express Photo by Amit Chakravarty) Vaccine against the coronavirus (Covid-19): After Pfizer, another US drugmaker, Moderna Inc, is likely to release the first …
Read More »
As Bharat Biotech aims to launch its vaccine, Covaxin, in February, which could be the first vaccine available in India, the Center is finalizing the procedure for administering the vaccine, including identifying the priority groups to target. they will administer the vaccine first and at no cost. . The group …
Read More »
According to a plan that was deliberated by a group of experts, state governments would identify buildings that can be used as vaccination booths under the special COVID-19 immunization program that would run in parallel to the Universal Immunization Program (UIP) existing. “Vaccination sites will not be limited to health …
Read More »